Physicians often rely on referrals for new patient flow through their practice. Unfortunately, most doctors network incorrectly, inconsistently and ineffectively.

The life science industry today has a significant opportunity at hand with the surge in data dependency. With the legislation of the 21st Century Cures Act, data has become the fuel for accelerating the drug development and innovation processes. The Cures Act defines the real-world evidence (RWE) as the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of the real-world data (RWD). This facilitates an accurate view of the patient populations comprising larger socioeconomic, racial, age, and gender diversity, mostly un-represented by the RCTs.

Patient CRM is a critical criterion for maintaining long-term relationships while viewing patients as people and emanating a vibe of personal care. Patient CRM has an important impact on the evolving healthcare ecosystem, wherein- building upon ongoing patient relationships can result in prolonged customer loyalty, convalescent goodwill, and enhanced market credibility. The potential can be leveraged by delivering value over price. Combining information on patient demographics, social profiles, behavioral data, medical and appointment history from disparate sources into one complete data set is key to successful relationship management.

Command Center is a centralized approach to operations, where, real-time and predictive analytics from disparate data sources is aggregated and used as a coordinated approach to managing multiple stakeholders within a hospital or a health system.

The 21st Century Act was launched primarily for facilitating the acceleration of cancer research, and extending precision medicine to all diseases through the Precision Medicine Initiative (PMI). The Cures Act supports the US Food and Drug Administration (FDA) to streamline the process for drug and medical device approvals, promote increased use of electronic health records, and advance the implementation of telehealth services. The Cures Act facilitates advancing the medical product development and speedy delivery of medical innovations for patients in need.

On September 29, 2020, our journey of getting two patents published finally culminated. With great pride and joy, we are extremely excited to share that two of our patents have been published by the U.S. Patent Office. Following are the patent details

Employee benefits strategies are swiftly changing in response to the evolving needs of today’s workforce, and employers understand that they need to take a closer look at their benefit plans and ensure they align with the demands of constantly changing work environments.

Due to the use of newer and more sophisticated technologies, the cost associated with developing drugs is steadily rising. The trend of medication personalization is also growing, which means the investments that go into research have to be paid for by fewer individuals, further increasing the cost of drugs.

The healthcare industry continues to seek new technologies to address the triple aim of access, cost and quality, and virtual care happens to be one of them. An array of virtual technologies has made it possible to bring better care to more people at lower costs. It is no longer necessary to travel in-person to a care facility, yet some challenges persist. The privacy and security of patient information is a major concern. Therefore, it is time to address these security concerns and keep them at bay.

Defining patient populations is an important first step when it comes to identifying opportunities for clinical improvement. The conversion and delivery of actionable information to appropriate resources are major challenges for healthcare organizations when managing population health. This conversion is highly dependent on knowing your patients, their needs and common patterns relevant to a disease.